PD-L1 Blockade Therapy: Location, Location, Location-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-L1 Blockade Therapy: Location, Location, Location

Published:2020-11 Issue:5 Volume:38 Page:615-617
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Brown Chrysothemis C.,Wolchok Jedd D.

Funder

Ludwig Institute for Cancer Research

National Institutes of Health

Cancer Research Institute

National Cancer Institute

Parker Institute for Cancer Immunotherapy

Wellcome Trust

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference8 articles.

1. Recruit or reboot? how does anti-PD-1 therapy change tumor-infiltrating lymphocytes?;Callahan;Cancer Cell,2019

2. The PD-1/PD-L1-checkpoint restrains T cell immunity in tumor-draining lymph nodes;Dammeijer;Cancer Cell,2020

3. A conserved dendritic-cell regulatory program limits antitumour immunity;Maier;Nature,2020

4. Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy;Mayoux;Sci. Transl. Med.,2020

5. PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer;Oh;Nat. Cancer,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-signal output biosensor for the detection of program death-ligand 1 and therapy progress monitoring of cancer;Biosensors and Bioelectronics;2024-10

2. Boosting Cancer Immunotherapy via Reversing PD-L1–Mediated Immunosuppression with a Molecularly Imprinted Lysosomal Nanodegrader;ACS Nano;2024-08-13

3. Mitochondria Energy Metabolism Depression as Novel Adjuvant to Sensitize Radiotherapy and Inhibit Radiation Induced‐Pulmonary Fibrosis;Advanced Science;2024-05-07

4. Neoadjuvant immunotherapy based on PD-1/L1 Inhibitors for gastrointestinal tumor: a review of rationale and clinical advances;International Journal of Surgery;2024-03-21

5. Progresses in biomarkers for cancer immunotherapy;MedComm;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3